Toray Industries, Inc. and Astellas Pharma Inc. Announce of the Acquisition of Marketing Approval for the Pulmonary Arterial Hypertension Agent Careload(R) LA Tablets 60mu/g in Japan
Published: Oct 22, 2007
Tokyo, Oct 22, 2007 (JCN Newswire) - Toray Industries Inc. (TSE: 3402) and Astellas Pharma Inc. (TSE: 4503) today announced that Toray has obtained marketing approval for its oral PGI2 derivative prolonged release, Careload(R) LA Tablets 60mu/g (generic name: beraprost sodium), to be indicated for pulmonary arterial hypertension (PAH) on October 19,2007. Careload will be listed in the NHI drug price list and launched in December 2007.